Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR54 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
mRNA | GPR87 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | C17orf99 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
mRNA | MED27 | FIMM | pan-cancer | AAC | -0.48 | 0.004 |
mRNA | GDPD3 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
mRNA | FAT2 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | KIF2A | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | JAK3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | HERPUD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |